[HTML][HTML] HIV subtype diversity worldwide
N Bbosa, P Kaleebu, D Ssemwanga - Current Opinion in HIV and …, 2019 - journals.lww.com
The dynamic change in HIV subtype distribution presents future challenges for diagnosis,
treatment and vaccine design and development. An increase in recombinant viruses suggests …
treatment and vaccine design and development. An increase in recombinant viruses suggests …
[PDF][PDF] Update on HIV-1 diversity in Africa: a decade in review
RW Lihana, D Ssemwanga, A Abimiku, N Ndembi - Aids Rev, 2012 - researchgate.net
Background: HIV-1 strains have diversified extensively through mutation and recombination
since their initial transmission to human beings many decades ago in Central Africa in the …
since their initial transmission to human beings many decades ago in Central Africa in the …
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
…, D Park, D Baker, D Doolabh, D Ssemwanga… - Science, 2021 - science.org
The progression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing
in Africa over the past year has led to a major increase in the number of sequences that have …
in Africa over the past year has led to a major increase in the number of sequences that have …
Update on HIV-1 acquired and transmitted drug resistance in Africa.
D Ssemwanga, RW Lihana, C Ugoji… - AIDS …, 2015 - search.ebscohost.com
The last ten years have witnessed a significant scale-up and access to antiretroviral therapy
in Africa, which has improved patient quality of life and survival. One major challenge …
in Africa, which has improved patient quality of life and survival. One major challenge …
[HTML][HTML] Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and …
…, MA Soares, VV Soriano, D Ssemwanga… - PLoS …, 2015 - journals.plos.org
Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …
[HTML][HTML] Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples
…, J Serwanga, B Kikaire, D Ssemwanga… - International Journal of …, 2021 - Elsevier
Objectives There is a high demand for SARS-CoV-2 testing to identify COVID-19 cases.
Real-time, quantitative PCR (qRT-PCR) is the recommended diagnostic test but a number of …
Real-time, quantitative PCR (qRT-PCR) is the recommended diagnostic test but a number of …
[HTML][HTML] Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda
Background International and global organisations advocate targeting interventions to areas
of high HIV prevalence (ie, hotspots). To better understand the potential benefits of geo-…
of high HIV prevalence (ie, hotspots). To better understand the potential benefits of geo-…
Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a …
D Ssemwanga, J Asio, C Watera… - Journal of …, 2020 - academic.oup.com
Objectives We implemented the WHO cross-sectional survey protocol to determine rates of
HIV viral load (VL) suppression (VLS), and weighted prevalence, predictors and patterns of …
HIV viral load (VL) suppression (VLS), and weighted prevalence, predictors and patterns of …
[HTML][HTML] Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones
…, GH Learn, L Yue, E Ruzagira, D Ssemwanga… - Virology, 2013 - Elsevier
We report the molecular identification, cloning and initial biological characterization of 12 full-length
HIV-1 subtype A, D and A/D recombinant transmitted/founder (T/F) genomes. T/F …
HIV-1 subtype A, D and A/D recombinant transmitted/founder (T/F) genomes. T/F …